Crossmark

EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1186/s40425-019-0784-9

Published Online: 2019-11-14

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xiao, Gang

Jin, Li-Lian

Liu, Chao-Qun

Wang, Yong-Chun

Meng, Ya-Ming

Zhou, Zhong-Guo

Chen, Jing

Yu, Xing-Juan

Zhang, Yao-Jun

Xu, Jing

Zheng, Limin https://orcid.org/0000-0002-8281-1450
Funding

Funding for this research was provided by:

Postdoctoral Research Foundation of China (2016M592586)

National 135 Major Project of China (2017YFA0505803, 2018ZX10302205)

National Natural Science Foundation of China (81702818, 81772536)

National Natural Science Foundation of China (81572387)

Fundamental Research Funds for the Central Universities under Grant (171gjc32)
License Information

Text and Data Mining valid from 2019-11-14
More Information

Article History

Received: 10 April 2019

Accepted: 22 October 2019

First Online: 14 November 2019

Ethics approval and consent to participate

: All authors approved and directly participated in the planning, execution and/or analysis of the data presented herein. The research presented here has been performed in accordance with the Declaration of Helsinki and has been approved by the Review Board of Sun Yat-sen University Cancer Center. The patients were informed about the sample collection and had signed informed consent forms.

: The content of this manuscript has not been previously published and is not under consideration for publication elsewhere.

: The authors declare that they have no competing interests.